United States Deep Venous Disease Treatment Devices Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The global Deep venous disease treatment devices market was valued at $1,119.5 million in 2022 and is anticipated to reach $2,419.4 million by 2032, witnessing a CAGR of 7.75% during the forecast period 2023-2032.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/deep-venous-disease-treatment-devices-market?sb

Key Development:

United States: Recent Deep Venous Disease Treatment Device Developments

✅ In November 2025, Inari Medical's FlowTriever System received FDA 510(k) clearance for treating right-atrial "clot in transit," expanding its use beyond pulmonary embolism. The update strengthens its positioning in acute venous intervention. It marks a major regulatory milestone for complex clot management.

✅ In January 2025, Stryker finalized its agreement to acquire Inari Medical for USD 4.9 billion, adding ClotTriever and FlowTriever systems to its vascular portfolio. The deal accelerates Stryker's expansion into venous intervention. It enhances its presence across deep venous disease treatment technologies.

✅ In October 2024, Inari Medical partnered with the American Venous Forum and the National Blood Clot Alliance to advance the DEFIANCE randomized trial. The study compares mechanical thrombectomy using ClotTriever versus anticoagulation. It aims to elevate evidence-based treatment for DVT.

Japan: Recent Deep Venous Disease Treatment Device Developments

✅ In November 2025, Inari Medical secured national reimbursement approval from Japan's Ministry of Health for its ClotTriever thrombectomy system in DVT, under a dedicated functional category.

✅ In May 2025, Japan initiated a 100-patient post-market surveillance study for the ClotTriever system. The study evaluates real-world outcomes following national reimbursement approval. It aims to guide broader adoption across Japanese vascular centers.

✅ In December 2024, Japan's Ministry of Health granted national reimbursement for the ClotTriever thrombectomy system, enabling wider clinical access. The classification under a new functional category supports standardized use. It marks a major regulatory win for venous intervention technologies.

Key Players:

=> Medtronic Plc, Vesper Medical Inc., enVVeno Medical Corporation, Inari Medical, Cook Medical and Boston Scientific Corporation among others.

Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=deep-venous-disease-treatment-devices-market

Key Segments:

By Device Type

Ablation Devices dominate the market due to their high effectiveness in treating chronic venous insufficiency and varicose veins. Growing adoption of minimally invasive thermal and non-thermal ablation technologies further strengthens their share.
Venous Stents hold a significant share, supported by rising cases of deep venous obstruction and strong demand for durable, long-term treatment solutions.
Venous Closure Products are witnessing steady growth, driven by increased preference for minimally invasive procedures and improved patient outcomes.
Sclerotherapy Injections remain widely used for cost-effective vein treatments, particularly in outpatient and ambulatory settings.
Vena Cava Filters occupy a smaller but essential segment due to their role in preventing pulmonary embolism in high-risk patients.
Others include compression devices and adjunct tools used across diagnosis and treatment pathways.

By End-User

Hospitals lead the market with the highest share owing to advanced treatment infrastructure, large patient inflows, and high adoption of endovascular procedures.
Ambulatory Surgical Centers (ASCs) show strong growth due to increasing shift toward outpatient minimally invasive venous procedures and lower surgery costs.
Specialty Clinics continue to expand, supported by rising demand for cosmetic vein treatments and advanced vascular care.
Others include standalone vascular centers and research facilities contributing selectively to market adoption.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/deep-venous-disease-treatment-devices-market?sb

By Region

North America
Holds the largest share driven by high prevalence of venous diseases, advanced healthcare infrastructure, and rapid adoption of minimally invasive venous treatment technologies in the U.S. and Canada.

Europe
Significant market presence due to robust reimbursement structures, increasing elderly population, and strong adoption of stents and ablation systems.

Asia Pacific
Fastest-growing region fueled by rising healthcare expenditure, growing awareness of venous disorders, expanding hospital networks, and improving access to advanced vascular treatments in China, India, and Japan.

Latin America
Moderate growth supported by expanding private healthcare facilities and rising demand for cost-effective vein treatment options.

Middle East & Africa
Steady growth due to improving healthcare systems, increasing investments in vascular care, and adoption of advanced treatment technologies in GCC countries and South Africa.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.